Back to Search
Start Over
Position of a panel of international lung cancer experts on the approval decision for use of durvalumab in stage III non-small-cell lung cancer (NSCLC) by the Committee for Medicinal Products for Human Use (CHMP).
- Source :
-
Annals of Oncology . Feb2019, Vol. 30 Issue 2, p161-165. 5p. - Publication Year :
- 2019
- Subjects :
- *NON-small-cell lung carcinoma
*LUNG cancer
*IPILIMUMAB
*PACLITAXEL
Subjects
Details
- Language :
- English
- ISSN :
- 09237534
- Volume :
- 30
- Issue :
- 2
- Database :
- Academic Search Index
- Journal :
- Annals of Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 134888987
- Full Text :
- https://doi.org/10.1093/annonc/mdy553